Treatment of Coxiella burnetii (Q Fever) Pneumonia

First-Line Treatment

The Centers for Disease Control and Prevention recommends doxycycline 100 mg twice daily for 14 days as the first-line treatment for adults and children ≥8 years with Q fever pneumonia 1
Treatment should be initiated immediately upon clinical suspicion of Q fever pneumonia and should not be delayed pending laboratory confirmation 1
Early treatment (within 24 hours of fever onset) is extremely effective in shortening illness duration and reducing symptom severity 2

For uncomplicated Q fever pneumonia in children <8 years, the Centers for Disease Control and Prevention recommends trimethoprim/sulfamethoxazole for 14 days or a shorter course (5 days) of doxycycline 1, 3
Pregnant women diagnosed with Q fever pneumonia should receive trimethoprim/sulfamethoxazole throughout the duration of pregnancy, as doxycycline is contraindicated during pregnancy 1, 4

The Centers for Disease Control and Prevention recommends serologic monitoring following acute Q fever infection to assess possible progression to chronic infection 1
High-risk patients (those with valvular heart disease, vascular abnormalities, immunosuppression) require more intensive follow-up 5

If Q fever pneumonia progresses to chronic infection, treatment consists of doxycycline 100 mg twice daily plus hydroxychloroquine 200 mg three times daily 5, 6
Treatment duration for chronic infection is much longer (18-24 months) depending on the site of infection 5
Monthly monitoring of antibody titers and clinical evaluations are required during treatment for chronic Q fever 5

The gold standard for diagnosis is a fourfold rise in phase II IgG antibody titer between acute and convalescent samples 7
PCR, immunohistochemistry, or culture of affected tissue can provide definitive confirmation of C. burnetii infection 7